Time and Location:
6-8 May 2024 |Berlin Congress Center Alexanderstraße 11, 10178 Berlin, Germany
INTRODUCTION
RAPS Convergence is the largest and most recognized annual gathering of global regulatory affairs professionals. Convergence brings together representatives of industry, regulatory bodies, research, academia, and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.
We’re thrilled to announce that our visionary CEO Helen Ye will take the stage to present Accestra Consulting. She will share valuable insights and expertise on the topics of Strategic Options of Regulatory Pathways for Drug Registration in China.
Presentation: Exploring Regulatory Pathways for Drug Registration in China:Strategic Approaches
7 May 2024, 15:05 – 16:05 (CET)
Key Takeaway Points
- Standard drug registration procedures in China
- Accelerated review pathways
- Special pathways to access China
- Registration strategy & tips
Presenter:
April Wang, Regulatory Affairs Manager at Accestra Consulting
- Ms. Wang is a senior regulatory affairs consultant specializing in the Chinese market with a Double Master’s Degree from Fudan University and Luiss Guido Carli University.
- She has in-depth understanding on Chinese Pharmaceutical regulations and accumulated extensive hands-on experience with DMF filing & regulatory consulting projects during daily work.
- Ms. Wang has strong communication network with Chinese authorities including NMPA and CDE.
- A successful track record with supporting international pharma with market entry into China including big and small pharma
See you there!
– Accestra Events Team
